Introduction {#sec1}
============

Heteroarene constructs bearing the indole functionality are ubiquitous in biologically active natural products,^[@ref1]^ medicinal chemistry,^[@ref2]^ synthesis,^[@ref3]^ and related areas.^[@ref4]^ Use of complexant scaffolds with the indole moiety in the context of radiochemical liquid--liquid separations of actinides from lanthanides has yet to appear. Sequestration of the minor actinides from the lanthanides is necessary for the use of these radionuclides in advanced fuels for further transmutation toward diminishing radiotoxicity, heat load, and long-term storage requirements of spent nuclear fuel in a geologic repository.^[@ref5]^ Lewis basic scaffolds with soft donor atoms, specifically, N, and based on the CHON principle,^[@ref6]^ have demonstrated effective performance in this area since Kolarik's disclosure of alkyl bis-triazinyl-1,2,4-triazine complexants (BTPs) for minor actinide separations.^[@ref7]^ In an effort to further define structure--activity relationships to potentially improve complexant performance, our lab has been engaged in the pursuit of scaffolds, which afford opportunities to leverage modular concepts for complexant construction.

We were interested in exploring the potential of tridentate, soft-Lewis basic \[1,2,4\] triazinyl-pyridin-2-yl complexants with an indole appendage in separations. A primary challenge in this area of separation science is to design a complexant, which displays significant binding affinity for the minor actinides over lanthanides while maximizing the covalency of the f-orbital interaction^[@ref8]^ of the metal--ligand complex to afford selective speciation, while at the same time providing an opportunity for subsequent stripping and reuse of the complexant for additional separations. Further issues include dissolution of a relatively planar, polar heteroaromatic scaffold in diluents with low polarity and facilitating good kinetics of complexation.^[@ref9]^

Facile phase separation in strongly acidic media involving HNO~3~ also presents issues. The diminished basicity of the indole N could offer potential in this area due to the lone pair participation in the aromaticity of the heterocycle and concomitant diminished potential for appreciable protonation under separation conditions. The complexants of current synthetic interest also possess structural characteristics to form "semifrustrated" Lewis acid/base pairs^[@ref10]^ due to the N--H bond, which may influence complexation. Metal-mediated coupling approaches to the formation of advanced heteroarenes have been facilitated by the Suzuki--Miyaura cross-coupling reaction of relevant organoboron moieties with a suitable electrophile leveraging Pd-catalysis. The versatility of this approach facilitated our interest in the development of this method for accessing procomplexants via cross-coupling with heteroarylboronic acids.

Results and Discussion {#sec2}
======================

[Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} describes selected efforts toward optimization of the desired Pd-catalyzed bond formation between 3-(6-bromo-pyridin-2-yl)-5,6-diphenyl-\[1,2,4\]triazine (**1**) and (1-(*tert*-butylcarbonyl)-5-(methoxy)-indol-2-yl)boronic acid utilizing Suzuki--Miyaura cross-coupling^[@ref11]^ as the model system. The overarching goal was to develop a method that utilized the absolute minimum of all reagents necessary. Initial definition of reaction conditions began with the evaluation of previously disclosed transformations described by us for sp^2^ C--sp^3^ N bond formation via Buchwald--Hartwig amination (entry 1) without success ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).^[@ref12]^ Modest conversion was realized for reagents from prior Suzuki--Miyaura^[@ref13]^ (entry 2) and Sonogashira cross-couplings^[@ref14]^ (entry 3) methods previously disclosed by us for similar substrates. Interested in improving conversion performance, additional catalyst/ligand combinations were evaluated.

###### Indole-Boronic Acid Coupling Development
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  entry[a](#t1fn1){ref-type="table-fn"}   catalyst (mol %)           ligand (mol %)        base (equiv)           solvent system[b](#t1fn2){ref-type="table-fn"}   temp (°C)   time (h)   conv (%)[c](#t1fn3){ref-type="table-fn"}
  --------------------------------------- -------------------------- --------------------- ---------------------- ------------------------------------------------ ----------- ---------- ------------------------------------------
  1                                       Pd(dba)~2~ (5%)            CyPF-*t*Bu (10%)      Cs~2~CO~3~ (3 equiv)   Tol:H~2~O (4:1)                                  115         16          
  2                                       Pd(OAc)~2~ (5%)            RuPhos (5%)           Cs~2~CO~3~ (3 equiv)   Tol:H~2~O (4:1)                                  115         16         76
  3                                       Pd(dppf)Cl~2~ (5%)                               Cs~2~CO~3~ (3 equiv)   Tol:H~2~O (4:1)                                  115         16         75
  4                                       Pd(OAc)~2~ (5%)            \[BuPAd~2~\]HI (5%)   Cs~2~CO~3~ (3 equiv)   Tol:H~2~O (4:1)                                  115         16          
  5                                       Pd(PPh~3~)~4~ (5%)                               Cs~2~CO~3~ (3 equiv)   Tol:H~2~O (4:1)                                  115         16         66
  6                                       Pd(PPh~3~)~2~Cl~2~ (5%)    PPh~3~ (5%)           Cs~2~CO~3~ (3 equiv)   Tol:H~2~O (4:1)                                  115         16         60
  7                                       Pd(OAc)~2~ (5%)            XPhos (5%)            Cs~2~CO~3~ (3 equiv)   Tol:H~2~O (4:1)                                  115         16         93
  8                                       Pd(dba)~2~ (5%)            XPhos (10%)           Cs~2~CO~3~ (3 equiv)   Tol:H~2~O (4:1)                                  115         16          
  9                                       XPhos-*t*Bu Pd G~3~ (5%)   XPhos-*t*Bu (5%)      Cs~2~CO~3~ (3 equiv)   Tol:H~2~O (4:1)                                  115         16         40
  10                                      Pd(dba)~2~ (2.5%)          XantPhos (5%)         Cs~2~CO~3~ (3 equiv)   Tol:H~2~O (4:1)                                  115         1          99
  11                                      Pd(dba)~2~ (2.5%)          XantPhos (5%)         Cs~2~CO~3~ (1 equiv)   Tol:H~2~O (4:1)                                  115         1          99
  12                                      Pd(dba)~2~ (2.5%)          XantPhos (5%)         Cs~2~CO~3~ (1 equiv)   MTBE:H~2~O (4:1)                                 55          16         85
  13                                      Pd(dba)~2~ (2.5%)          XantPhos (5%)         Cs~2~CO~3~ (1 equiv)   CPME:H~2~O (4:1)                                 106         0.75       99(73)[d](#t1fn4){ref-type="table-fn"}
  14                                      Pd(dba)~2~ (1%)            XantPhos (2%)         Cs~2~CO~3~ (1 equiv)   CPME:H~2~O (4:1)                                 106         16         90
  15                                                                 XantPhos (5%)         Cs~2~CO~3~ (1 equiv)   CPME:H~2~O (4:1)                                 106         16          
  16                                      Pd(dba)~2~ (2.5%)                                Cs~2~CO~3~ (1 equiv)   CPME:H~2~O (4:1)                                 106         16          
  17                                      Pd(dba)~2~ (2.5%)          XantPhos (5%)                                CPME:H~2~O (4:1)                                 106         16          

(1-(*tert*-Butylcarbonyl)-5-(methoxy)-indol-2-yl)boronic acid (1.05 equiv).

Reaction concentration at 0.2 M (total).

Conversion determined from the integration of select resonances in the ^1^H NMR spectrum without internal standard.

Isolated, purified yield. CyPF-*t*Bu = 1-dicyclohexylphosphino-2-di-*t*-butylphosphinoethylferrocene, CPME = cyclopentyl methyl ether, MTBE = methyl-*tert*-butyl ether.

Entries 4--6 with Pd^2+^ and Pd^0^ sources, respectively, did not improve upon entry 2. Combining Pd(OAc)~2~ with the alkylbiaryl phosphine XPhos, developed by Buchwald,^[@ref15]^ afforded 93% conversion after 16 h (entry 7). Transitioning to Pd(dba)~2~ (entry 8), as well as the matched *t*BuXPhos precatalyst (entry 9), afforded 0 and 40% conversion, respectively. Expansion of ligand diversity to Xantphos^[@ref16]^ with a large 108° bite angle to accelerate reductive elimination, in combination with Pd(dba)~2~, afforded 99% conversion of the starting material after just 1 h at 115 °C (entry 10). Minimal Boc deprotection of the product was observed in this case. Decrease of the base loading to 1 equiv did not result in the exclusion of Boc deprotection but still maintained excellent conversion (entry 11). Lowering the temperature to 55 °C in toluene extended the reaction time (16 h), as expected, but did not improve the impurity profile of the crude reaction mixture. Improving the efficiency of the transformation was, subsequently, attempted employing a solvent screen with ethereal solvents methyl-*tert*-butyl ether (MTBE) and cyclopentyl methyl ether (CPME) at their respective boiling points (entries 12 and 13). Entry 12 produced the cleanest transformation overall, but at lower conversion, whereas entry 13 afforded high conversion, no Boc deprotection in the proof of concept example, and a manageable impurity profile affording the desired product **2** in 73% isolated yield in an expeditious reaction time of 45 min. Reduction of the catalyst and ligand loading to 1 and 2%, respectively (entry 14), resulted in longer reaction time, lower conversion, and a worse impurity profile. The requisite control experiments were performed to underscore the necessity of all reagents to afford **2** (entries 15--17). With a viable procedure for the construction of the critical pyridin-2-yl-indole C--C bond defined, focus shifted toward the evaluation of the indole scope of the transformation ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Experiments were performed to understand the electronic preferences of the catalyst/ligand system.

###### Indole-Boronic Acid Scope[a](#t2fn1){ref-type="table-fn"}^,^[b](#t2fn2){ref-type="table-fn"}^,^[c](#t2fn3){ref-type="table-fn"}^,^[d](#t2fn4){ref-type="table-fn"}^,^[e](#t2fn5){ref-type="table-fn"}^,^[f](#t2fn6){ref-type="table-fn"}
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Reaction Conditions: **1** (0.258 mmol), Pd(dba)~2~ (0.006 mmol), Xantphos (0.013 mmol), indole-boronic acid (0.270 mmol), Cs~2~CO~3~ (0.774 mmol), CPME:H~2~O (4:1) (0.20 M), and heated for time indicated.

Isolated, purified yield over one synthetic step.

Average yield from two experiments.

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1*H*-indole used as the indole boron reagent.

Pd(dba)~2~ (0.010 mmol) and Xantphos (0.019 mmol) utilized.

2,6-Dibromopyridine used as the substrate with described conditions and 2.10 equiv of coupling reagent; yield over 2 steps.

Treatment of **1** with the unfunctionalized, indole-boronic acid resulted in the desired complexant **3** in 78% yield (entry 1). The weakly electron-donating methyl substituent in **4** afforded the lowest yield (47%) of the indole boron reagent examples evaluated in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} (entry 2) due, in part, to purification challenges. The method was tolerant of inductive electron-withdrawing (entries 3 and 4) as well as resonance-donating substituents (entry 5), on the indole-boronic acid with the substituent in the 5-position.^[@ref17]^ Substituent transposition to the 6-position in the case of resonance-donating groups afforded the desired products **7** and **8**. The success of the transmetallating indole boron species was not limited to boronic acids. Treatment of **1** with the pinacol ester indole derivative afforded the desired product **10** in good yield. Employment of this reagent in the context of a double cross-coupling experiment with 2,6-dibromopyridine (entry 11) was also successful leading to the formation of **12** in 85% yield over two steps from **1**.^[@ref18]^ Exchange of the heteroatom in the boronic acid to the more electron-withdrawing oxygen atom in the case of entry 10 was successful but afforded **11** in a modest 37% yield.^[@ref19]^ It is also noteworthy that when the boronic acid functional group was located in the 5-position of the indole, successful coupling was not realized suggesting that effective transmetallation and/or reductive elimination of the desired product were predicated on the boronic acid being present in the 2-position relative to the indole.

Having ascertained that the desired substrates were tolerant of electronically diverse indole coupling reagents, efforts shifted to the variation of the electrophile and cross-coupling reagent toward potentially improving complexant solubility and separations outcomes in process-relevant diluents ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}).

###### Scaffold Diversification Scope[a](#t3fn1){ref-type="table-fn"}^,^[b](#t3fn2){ref-type="table-fn"}^,^[c](#t3fn3){ref-type="table-fn"}^,^[d](#t3fn4){ref-type="table-fn"}^,^[e](#t3fn5){ref-type="table-fn"}
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Reaction Conditions: **1** (0.258 mmol), Pd(dba)~2~ (0.006 mmol), Xantphos (0.013 mmol), indole-boronic acid (0.270 mmol), Cs~2~CO~3~ (0.774 mmol), CPME:H~2~O (4:1) (0.20 M), and heated for time indicated.

Isolated, purified yield over one synthetic step.

Average yield from three experiments.

Employed 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1*H*-indole as the indole boron reagent.

Two chromatographic purifications required.

[Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"} highlights the diversified combination of the substrate and indole-boronic acids. Interestingly, when a weakly electron-donating substituent is placed on the electrophile and paired with the same functionality on the indole-boronic acid (entry 1), a satisfactory coupling outcome (**13**) is afforded. However, when the same substrate is combined with an unfunctionalized-Boc-protected indole-boronic acid, a modest 38% yield (**14**) is afforded. The low yield in the case of **14** is primarily due to purification issues with this combination, which proved the most difficult in the entire project. Combining an electron-withdrawing functionality in the case of a F-substituent on the substrate with electron-withdrawing (entry 3) and electron-donating (entry 4) functionalities rendered little difference in the product formation. Complexants bearing the 3,3′-methoxy substituent on the 1,2,4-triazinyl moiety have demonstrated acumen in separations processes.^[@ref20]^ Evaluation of this synthon with the 5-methoxy- (entry 5) and 4-methyl-Boc-protected (entry 8) indole-boronic acids resulted in similar performance affording **17** and **20** in 61 and 56% isolated yield, respectively.

The study of complexant scaffolds with aliphatic functionality is an important area of focus for this laboratory. Entries 9--11 with butyl and 3-methylbutyl substituents on the arene moiety of the electrophile performed similarly with resonance-donating, neutral, and electron-withdrawing functionalities (**22**, **23**, and **21**, respectively). Entries 12 and 13 with the 6-benzyloxy- substituent on the Boc-protected indole-boronic acid were achievable, but yield issues were experienced in both cases (**24** and **25**) with two flash purifications on acidic Al~2~O~3~ required to obtain a spectroscopically clean material from **25**.

An issue among Suzuki--Miyaura cross-coupling methods is the performance variation of boron reagent within the confines of a specific catalyst--ligand combination. Diversity of the boron reagent can lead to substantive deviation in method performance.^[@ref21]^ Interested in ascertaining the applicability of alternative boron reagents with **1**,^[@ref22]^ evaluations of the boronic acid, pinacol ester, potassium trifluoroborate, and MIDA^[@ref23]^ ester of benzene were studied ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}). Results toward **26** sought to evaluate the performance differences between transmetallating reagents with **1** and the current catalyst/ligand system.^[@ref24]^

###### Boron Reagent Scope[a](#t4fn1){ref-type="table-fn"}
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  entry[a](#t4fn1){ref-type="table-fn"}   R             time (h)   conv (%)[b](#t4fn2){ref-type="table-fn"}   yield (%)[c](#t4fn3){ref-type="table-fn"}
  --------------------------------------- ------------- ---------- ------------------------------------------ -------------------------------------------
  1                                       B(OH)~2~      21         100                                        69
  2                                       BF~3~K        16         85                                         30
  3                                       B(*pin*)~2~   21         56                                         \-\--
  4                                       BMIDA         16         28                                         \-\--

Reaction conditions: **1** (0.258 mmol), Pd(dba)~2~ (0.006 mmol), Xantphos (0.013 mmol), Boron reagent (0.270 mmol), Cs~2~CO~3~ (0.774 mmol), CPME:H~2~O (4:1) (0.20 M), and heated for time indicated.

Percent conversion determined from integration of selected resonances in the ^1^H NMR spectrum without internal standard.

Isolated, purified yield.

Phenyl boronic acid (entry 1) afforded the highest conversion in the shortest period of time but profoundly slower than the comparable indole-boronic acids suggesting that the presence of the N atom on the arene had a marked influence in accelerating the rate of transmetallation or reductive elimination toward product formation. The case of potassium phenyltrifluoroborate (entry 3) afforded 85% conversion but a poor isolated yield. It is important to mention that **1** was successfully coupled and purified with other potassium aryl, and even alkyltrifluoroborates, in our previous work^[@ref25]^ suggesting that this catalytic system is less effective for these reagents. Entry 3 with the phenyl pinacol ester afforded modest conversion even though the indole derivative performed well ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 12). Low conversion in the case of the phenyl MIDA reagent^[@ref26]^ was observed (entry 4). In both of the aforementioned cases of low conversion, it is postulated that protodeboronation of the boron reagent occurred affording benzene, which, subsequently, boiled off of the reaction at the temperature performed.

Production of sufficient quantities of a given complexant scaffold for full solubility and separation efficacy via scale-up of a development scale transformation can frequently present challenges. With the aforementioned in mind, a 10-fold scale-up transformation of **1** to **2** ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry 5) was executed with equivalent stoichiometry to the development of scale transformation. Pleasingly, the conversion, purification, and isolation were commensurate with the development scale affording **2** in a slightly improved 78% yield over the development example described in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![Tenfold Scale-Up Experiment](ao9b02891_0001){#sch1}

Conclusions {#sec3}
===========

In summary, we have disclosed a potent catalytic system for the construction of tridentate, semifrustrated 2-\[6-(5,6-diphenyl-\[1,2,4\]triazin-3-yl)-pyridin-2-yl\]-1*H*-indole complexants and related derivatives with low catalyst/ligand loadings, wide substrate scope, and good functional group tolerance. This work bears relevance to the construction of the challenging pyridin-2-yl indole C--C bond and should find further applicability in medicinal chemistry and related areas. Exploration of this class of complexants for potential application in minor actinide separations as well as defining experimental conditions for Boc deprotection are currently ongoing in this laboratory and will be reported in due course.

Experimental Section {#sec4}
====================

General Considerations {#sec4.1}
----------------------

All reagents were purchased from US chemical suppliers, stored according to published protocols, and used as received unless indicated otherwise. All experiments were performed in an oven- or flame-dried glassware. Reaction progress was monitored using thin-layer chromatography on glass-backed basic Al~2~O~3~ plates and/or ^1^H NMR analysis of crude reaction mixtures. *R*~*f*~ values for compounds that resulted in a concentrically observed spot on basic alumina TLC plates are reported using the conditions listed. Melting point data listed is for a single, uncorrected experiment unless noted otherwise. All reported yields listed are for pure compounds and corrected for the residual solvent, if applicable, from ^1^H NMR spectroscopy unless otherwise indicated. Infrared spectral data were acquired using attenuated total reflectance (ATR) from the (form) listed. All ^1^H and ^13^C NMR data were acquired from a 500 MHz multinuclear spectrometer with a broadband N~2~ cryoprobe. Chemical shifts are reported using the δ scale and are referenced^[@ref27]^ to the residual solvent signal: CDCl~3~ (δ 7.26), CD~3~CN (δ 1.94), (CD~3~)~2~C=O (δ 2.05), CD~5~CD~3~ (δ 6.97), and (CD~3~)~2~S=O (δ 2.50) for ^1^H NMR and chloroform (δ 77.16), CD~3~CN (δ 1.32), (CD~3~)~2~C=O (δ 29.84), CD~5~CD~3~ (δ 137.48), and (CD~3~)~2~S=O (δ 39.52) for ^13^C NMR. Splittings are reported as follows: (s) = singlet, (d) = doublet, (t) = triplet, (dd) = doublet of doublets, (dt) = doublet of triplets, (ddd) = doublet of doublet of doublets, (br) = broad, (br-m) = broad multiplet, and (m) = multiplet. ^13^C NMR spectra were corrected for ringdown using linear back prediction. High-resolution mass spectrometry (HRMS) data were obtained utilizing electron impact ionization (EI) with a magnetic sector (EBE trisector), double focusing-geometry mass analyzer.

Special Instructions {#sec4.2}
--------------------

It should be noted that products afforded in the context of the described method demonstrate significant sensitivity to the residual acidity in chloroform and dichloromethane, even when buffered. Pursuant to the aforementioned, these solvents should be avoided where possible for the purposes of chromatographic purification, transfer, and/or NMR analysis. Acetone and acetonitrile were suitable alternatives for this work. Most products display limited solubility in methanol. Additionally, prepared materials appear to readily incorporate the residual solvent into the crystal lattice, which is challenging to remove via standard reduced pressure techniques. Azeotropic removal of the residual acetone and/or ethyl acetate with acetonitrile afforded dry, residual solvent-free compounds at a much faster rate than freeze, pump, thaw strategies.

Starting Material Preparation {#sec4.3}
-----------------------------

For a general procedure on the preparation of the requisite 3-(6-bromo-pyridin-2-yl)-5,6-diphenyl-\[1,2,4\]triazine starting materials see: refs ([@ref28]−[@ref30]) below.

### 1,2-Bis-\[4-(3-methyl-butyl)-phenyl\]-ethane-1,2-dione {#sec4.3.1}

An adaptation of a literature protocol was employed.^[@ref28]^ To an 8 mL reaction vial equipped with a magnetic stirring bar, at ambient temperature was charged, and 4,4′-dibromobenzil (0.500 g, 1.36 mmol, 1.00 equiv), Pd(OAc)~2~ (15.3 mg, 0.60 mmol, 0.05 equiv), RuPhos (67.5 mg, 0.14 mmol, 0.10 equiv), 3-methylbutylboronic acid (0.331 g, 2.85 mmol, 2.10 equiv), and Cs~2~CO~3~ (1.328 g, 4.08 mmol, 3.00 equiv) were charged successively. The resulting mixture was slurried in toluene:H~2~O (4:1) (5.43 mL, 0.2 M) and heated to 110 °C upon which time the starting material had been consumed as evidenced from TLC and ^1^H NMR analyses. The crude mixture was directly absorbed on the silica gel, and the solvent was removed under reduced pressure at ambient temperature. The crude residue was purified on a silica gel column using automated flash column chromatography to afford the title compound. *R*~*f*~ = 0.63, 1% methyl-*tert*-butyl ether:hexanes; eluent, methyl-*tert*-butyl ether/hexanes (gradient); isolated yield 0.307 g, 64%; pale-greenish white solid; melting point = 63.1--64.6 °C; ^1^H NMR 500 MHz, (CDCl~3~): δ = 7.89--7.86 (m, 4H), 7.32--7.29 (m, 4H), 2.71--2.05 (m, 4H), 1.63--1.47 (m, 6H), 0.93 (d, *J* = 6.5 Hz, 12H); ^13^C NMR{^1^H} 125 MHz, (CDCl~3~): δ = 194.7, 151.4, 131.0, 130.3, 129.2, 40.4, 34.2, 27.8, 22.6; IR ATR-(neat): υ̅~max~ = 3063, 3036, 2957, 2929, 2906, 2869, 1668, 1602, 1571, 1219, 1170, 885 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~24~H~30~O~2~ 350.2246; Found: 350.2238.

### 3-(6-Bromo-pyridin-2-yl)-5,6-bis-\[4-(3-methyl-butyl)-phenyl\]-\[1,2,4\]triazine {#sec4.3.2}

An adaptation of a literature protocol was employed.^[@ref29]^ To a 25 mL round-bottom flask equipped with a magnetic stirring bar at ambient temperature was added 6-bromo-pyridine-2-carbonitrile (0.139 g, 0.76 mmol, 1.00 equiv) in anhydrous tetrahydrofuran (1.11 mL, 8 vol). The resulting clear solution was treated with hydrazine hydrate-64% hydrazine (0.22 mL, 4.57 mmol, 6 equiv) drop wise at ambient temperature. The resulting mixture was heated to 40 °C for 12 h upon which time the mixture was cooled to 0 °C in an ice bath to facilitate precipitation. The solids were isolated under reduced pressure, and the filter cake was conditioned with hexanes (0 °C) (3 × 10 mL). The resulting solids were dried under reduced pressure at ambient temperature, and then telescoped directly to the condensation step. Stoichiometry for the condensation was based on 100% conversion of the input. The telescoped solids were slurried in anhydrous THF (1.30 mL, 8 vol) at ambient temperature and treated with 1,2-bis-\[4-(3-methyl-butyl)-phenyl\]-ethane-1,2-dione, prepared as described above, (0.280 g, 0.80 mmol, 1.05 equiv) in one portion. The resulting mixture was heated to 66 °C for 12 h upon which time the mixture was cooled to ambient temperature and directly absorbed onto normal phase silica gel under reduced pressure at ambient temperature. The crude material was purified using automated flash column chromatography to afford the title compound. *R*~*f*~ = 0.56, 20% EtOAc:hexanes; eluent, methyl-*tert*-butyl ether/hexanes (gradient); isolated yield 0.188 g, 47%; bright yellow solid; melting point = 89.6--92.4 °C; ^1^H NMR 500 MHz, (CDCl~3~): δ = 8.62 (dd, *J* = 0.6, 7.7 Hz, 1H), 7.77 (t, *J* = 7.8 Hz, 1H), 7.66 (dd, *J* = 0.6, 7.9 Hz, 1H), 7.65--7.61 (m, 2H), 7.58--7.54 (m, 2H), 7.21 (d, *J* = 8.1 Hz, 2H), 7.17 (d, *J* = 8.1 Hz, 2H), 2.69--2.60 (m, 4H), 1.67--1.46 (m, 6H), 0.94 (d, *J* = 6.9 Hz, 6H), 0.93 (d, *J* = 6.9 Hz, 6H); ^13^C NMR{^1^H} 125 MHz, (CDCl~3~): δ = 159.5, 156.6, 156.2, 154.3, 146.8, 145.4, 143.0, 139.3, 132.9, 132.7, 130.1, 129.6, 128.83, 128.75, 123.0, 40.6, 40.5, 33.9, 33.8, 27.9, 27.8, 22.7, 22.6, one carbon resonance was phased out during acquisition or overlapped with another carbon resonance; IR ATR-(neat): υ̅~max~ = 3032, 2954, 2927, 2867, 1609, 1575, 1557, 1491, 1377, 1360, 819, 797, cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~32~H~37~BrN~4~ 528.1889; Found: 528.1883.

General Procedure for Indole-Boronic Acid Coupling {#sec4.4}
--------------------------------------------------

To an 8 mL reaction vial equipped with a magnetic stirring bar at ambient temperature was charged the requisite 3-(6-bromo-pyridin-2-yl)-5,6-diphenyl-\[1,2,4\]triazine (or derivative) (100 mg, 0.258 mmol, 1.00 equiv), followed by palladium dibenzylidene acetone (3.45 mg, 0.006 mmol, 0.025 equiv), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (XantPhos) (7.52 mg, 0.013 mmol, 0.05 equiv), the required indole-boronic acid, or analogous coupling reagent (1.05 equiv), and Cs~2~CO~3~ (84 mg, 0.258 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (0.86 mL, 0.20 M total) and heated to 106 °C in a vial apparatus for 0.75 h upon which time the reaction mixture turned from clear to dark brown and TLC analysis on basic Al~2~O~3~ demonstrated the consumption of starting material. TLC results were, subsequently, benchmarked by ^1^H NMR spectroscopy to determine percent conversions, relevant impurity profile, and support further purification of the crude material. The crude reaction mixtures were directly absorbed on celite and purified using automated flash column chromatography on an acidic alumina stationary phase, with an isocratic mobile phase consisting of 8% \[(3:1-ethyl acetate:acetone):hexanes\] to afford the title compounds in the morphologies indicated. All yields reported are for pure materials and take into consideration the residual solvent, if applicable.

### 2-\[6-(5,6-Diphenyl-\[1,2,4\]triazin-3-yl)-pyridin-2-yl\]-5-methoxy-indole-1-carboxylic Acid *tert*-Butyl Ester (**2**) {#sec4.4.1}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-diphenyl-\[1,2,4\]triazine (**1**) (0.1000 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), 1-(*tert*-butylcarbonyl)-5-(methoxy)-indol-2-yl)boronic acid (0.0786 g, 0.270 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.34, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.105 g, 73%; light yellow powder; melting point = 164.2--165.8 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 9.09 (d, *J* = 7.8 Hz, 1H), 8.63 (t, *J* = 7.9 Hz, 1H), 8.57 (d, *J* = 9.1 Hz, 1H), 8.33 (d, *J* = 7.8 Hz, 1H), 8.16 (d, *J* = 7.7 Hz, 2H), 8.12 (d, *J* = 7.6 Hz, 2H), 7.99--7.82 (m, 6H), 7.64 (d, *J* = 2.2 Hz, 1H), 7.46 (dd, *J* = 2.3, 9.1 Hz, 1H), 7.38 (s, 1H), 4.31 (s, 3H), 1.72 (s, 9H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 161.8, 157.4, 157.2, 156.8, 154.6, 153.7, 150.7, 140.9, 138.4, 136.9, 136.8, 133.3, 131.5, 130.9, 130.54, 130.55, 130.48, 130.47, 129.4, 129.3, 125.6, 123.4, 116.3, 114.9, 111.8, 104.1, 83.9, 55.9, 27.7; IR ATR-(neat): υ̅~max~ = 3059, 2977, 2933, 1728, 1587, 1569, 1477, 1446, 1366, 1323, 1219, 1157, 1118, 1025, 767, 695 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~34~H~29~N~5~O~3~ 555.2270; Found: 555.2263.

### 2-\[6-(5,6-Diphenyl-\[1,2,4\]triazin-3-yl)-pyridin-2-yl\]-indole-1-carboxylic Acid *tert*-Butyl Ester (**3**) {#sec4.4.2}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyr-idin-2-yl)-5,6-diphenyl-\[1,2,4\]triazine (**1**) (0.0996 g, 0.270 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.8 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.9 mg, 0.014 mmol, 0.05 equiv), (1-(*tert*-butylcarbonyl)-indol-2-yl)boronic acid (0.0705g, 0.270 mmol, 1.05 equiv), and C~s2~CO~3~ (0.841 g, 0.258 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.22, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.106 g, 78%; yellow crystalline solid; melting point = 95.1--97.7 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.65 (dd, *J* = 0.8, 7.9 Hz, 1H), 8.22 (dd, *J* = 0.5, 8.4 Hz, 1H), 8.18 (t, *J* = 7.8 Hz, 1H), 7.90 (dd, *J* = 0.8, 7.8 Hz, 1H), 7.73--7.64 (m, 5H), 7.52--7.37 (m, 7H), 7.28 (dt, *J* = 0.8, 7.5 Hz, 1H), 7.00 (s, 1H), 1.27 (s, 9H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 161.7, 157.4, 156.7, 154.5, 153.6, 150.7, 140.3, 138.7, 138.5, 136.82, 136.81, 131.5, 130.8, 130.5, 129.7, 129.4, 129.3, 125.8, 125.5, 123.8, 123.4, 122.0, 115.4, 111.8, 84.1, 27.7; IR (ATR-(CD~3~)~2~C=O): υ̅~max~ = 3059, 2978, 2931, 1732, 1702, 1590, 1570, 1493, 1446, 1385, 1368, 1327, 1160, 770, 697 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~33~H~27~N~5~O~2~ 525.2162; Found: 525.2166.

### 2-\[6-(5,6-Diphenyl-\[1,2,4\]triazin-3-yl)-pyridin-2-yl\]-4-methyl-indole-1-carboxylic Acid *tert*-Butyl Ester (**4**) {#sec4.4.3}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-diphenyl-\[1,2,4\]triazine (**1**) (0.1000 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.52 mg, 0.013 mmol, 0.05 equiv), (1-(*tert*-butylcarbonyl)-4-(methyl)-indol-2-yl)boronic acid (0.0743 g, 0.270 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.50, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.065 g, 47%; light yellow powder; melting point = 141.5--142.6 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.64 (dd, *J* = 0.7, 7.9 Hz, 1H), 8.19 (t, *J* = 7.9 Hz, 1H), 8.03 (d, *J* = 8.5 Hz, 1H), 7.93 (dd, *J* = 0.8, 7.8 Hz, 1H), 7.74--7.70 (m, 2H), 7.68--7.65 (m, 2H), 7.52--7.39 (m, 6H), 7.29 (t, *J* = 7.7 Hz, 1H), 7.09 (d, *J* = 7.4 Hz, 1H), 7.07 (br-s, 1H), 2.57 (s, 3H), 1.27 (s, 9H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 161.8, 157.4, 156.8. 154.7. 153.6, 150.8, 139.8, 138.5, 138.4, 136.9, 136.8, 131.5, 131.4, 130.9, 130.5, 130.4× (overlaps with 130.5), 129.4, 129.31, 129.27, 125.9, 125.4, 124.1, 123.4, 113.0, 110.3, 84.0, 27.7, 19.0; IR ATR-(neat): υ̅~max~ = 3054, 2977, 2930, 1731, 1588, 1570, 1492, 1445, 1412, 1368, 1326, 1141, 768, 694 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~34~H~29~N~5~O~2~ 539.2321; Found: 539.2308.

### 2-\[6-(5,6-Diphenyl-\[1,2,4\]triazin-3-yl)-pyridin-2-yl\]-5-fluoro-indole-1-carboxylic Acid *tert*-Butyl Ester (**5**) {#sec4.4.4}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-diphenyl-\[1,2,4\]triazine (**1**) (0.1002 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.6 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), (1-(*tert*-butylcarbonyl)-5-(fluoro)-indol-2-yl)boronic acid (0.0771 g, 0.276 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0825 g, 0.253 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.48, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.087 g, 62%; light yellow powder; melting point = 119.6--121.2 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.67 (dd, *J* = 0.9, 7.9 Hz, 1H), 8.23--8.19 (m, 2H), 7.93 (dd, *J* = 0.9, 7.7 Hz, 1H), 7.73--7.70 (m, 2H), 7.68--7.65 (m, 2H), 7.52--7.40 (m, 7H), 7.19 (dt, *J* = 2.6, 9.3 Hz, 1H), 7.00 (s, 1H), 1.27 (s, 9H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 161.7, 160.2 (d, *J* = 238.0 Hz), 157.4, 156.8, 154.2, 153.7, 150.5, 142.0, 138.5, 136.82, 136.79, 135.0, 131.5, 130.8, 130.6, 130.54, 130.47, 129.4, 129.3, 125.6, 123.7, 116.8 (d, *J* = 9.2 Hz), 113.4 (d, *J* = 25.5 Hz), 111.4, 107.1 (d, *J* = 24.0 Hz), 84.4, 27.7; IR (ATR-(CD~3~)~2~C=O): υ̅~max~ = 3059, 2977, 2932, 1765, 1589, 1571, 1475, 1446, 1369, 1348, 1329, 1158, 1112, 769, 695 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~33~H~28~FN~5~O~2~ 543.2071; Found: 543.2086.

### 2-\[6-(5,6-Diphenyl-\[1,2,4\]triazin-3-yl)-pyridin-2-yl\]-5-bromo-indole-1-carboxylic Acid *tert*-Butyl Ester (**6**) {#sec4.4.5}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-diphenyl-\[1,2,4\]triazine (**1**) (0.100 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), (1-(*tert*-butylcarbonyl)-5-(bromo)-indol-2-yl)boronic acid (0.0918 g, 0.268 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.48, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.112 g, 72%; light yellow powder; melting point = 136.4--138.2 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.67 (dd, *J* = 0.9, 7.8 Hz, 1H), 8.21 (t, *J* = 7.8 Hz, 1H), 8.15 (d, *J* = 8.9 Hz, 1H), 7.94 (dd, *J* = 0.9, 7.8 Hz, 1H), 7.88 (d, *J* = 2.0 Hz, 1H), 7.73--7.69 (m, 2H), 7.68--7.65 (m, 2H), 7.55--7.39 (m, 7H), 7.00 (s, 1H), 1.27 (s, 9H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 161.7, 157.5, 156.8, 154.0, 153.8, 150.4, 141.6, 138.6, 137.4, 136.9, 136.8, 131.6, 131.5, 130.9, 130.5, 129.4, 129.3, 128.4, 125.7, 124.5, 123.8, 117.3, 116.5, 110.8, 84.7, 27.6, one carbon was phased out, or overlapped during acquisition, and was not detected; IR ATR-(neat): υ̅~max~ = 3059, 2977, 2932, 1733, 1589, 1570, 1493, 1443, 1366, 1321, 1338, 1156, 1137, 768, 694 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~33~H~28~BrN~5~O~2~ 603.1270; Found: 603.1277.

### 6-(*tert*-Butyl-dimethyl-silanyloxy)-2-\[6-(5,6-diphenyl-\[1,2,4\]triazin-3-yl)-pyridin-2-yl\]-indole-1-carboxylic Acid *tert*-Butyl Ester (**7**) {#sec4.4.6}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-diphenyl-\[1,2,4\] triazine (**1**) (0.1000 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), (1-(*tert*-butylcarbonyl)-6-(*tert*-butyldimethylsilyl)-indol-2-yl)boronic acid (0.1057 g, 0.270 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.258 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.59, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.111 g, 66%; yellow solid; melting point = 108.7--109.6 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.65 (d, *J* = 7.8 Hz, 1H), 8.18 (t, *J* = 7.8 Hz, 1H), 8.09 (d, *J* = 8.8 Hz, 1H), 7.88 (d, *J* = 7.7 Hz, 1H), 7.73--7.69 (m, 2H), 7.68--7.64 (m, 2H), 7.52--7.38 (m, 6H), 7.15 (d, *J* = 2.3 Hz, 1H), 6.97 (dd, *J* = 2.3, 9.0 Hz, 1H), 6.91 (s, 1H), 1.26 (s, 9H), 1.03 (s, 9H), 0.25 (s, 6H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 161.8, 157.4, 156.8, 154.6, 153.7, 152.5, 150.7, 141.0, 138.4, 136.88, 136.86, 133.9, 131.5, 130.9, 130.7, 130.49, 130.48, 129.4, 129.3, 125.6, 123.5, 119.3, 116.2, 111.8, 111.6, 83.9, 27.7, 26.1, 18.8, −4.3; IR ATR-(neat): υ̅~max~ = 3061, 2955, 2929, 2886, 2856, 1732, 1615, 1589, 1571, 1471, 1446, 1347, 1225, 1158, 1125, 867, 857, 837, 695 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~39~H~41~N~5~O~3~Si 655.2979; Found: 655.2955.

### 6-Benzyloxy-2-\[6-(5,6-diphenyl-\[1,2,4\]triazin-3-yl)-pyridin-2-yl\]-indole-1-carboxylic Acid *tert*-Butyl Ester (**8**) {#sec4.4.7}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-diphenyl-\[1,2,4\]triazine (**1**) (0.1000 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), (1-(*tert*-butylcarbonyl)-6-(benzyloxy)-indol-2-yl)boronic acid (0.0776 g, 0.271 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.36, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.133 g, 82%; gold solid; melting point = 105.4--106.7 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 9.07 (dd, *J* = 0.8, 8.0 Hz, 1H), 8.61 (t, *J* = 7.8 Hz, 1H), 8.35 (d, *J* = 2.2 Hz, 1H), 8.33 (dd, *J* = 0.8, 7.8 Hz, 1H), 8.19--8.14 (m, 2H), 8.13--8.09 (m, 2H), 8.02 (d, *J* = 8.9 Hz, 1H), 8.01 (d, *J* = 7.5 Hz, 2H), 7.98--7.83 (m, 8H), 7.81--7.76 (m, 1H), 7.48 (dd, *J* = 2.3, 8.6 Hz, 1H), 7.39 (s, 1H), 5.69 (s, 2H), 1.71 (s, 9H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 161.8, 158.5, 157.4, 156.8, 154.7, 153.6, 150.9, 139.8, 139.4, 138.44, 138.36, 136.9, 131.5, 130.9, 130.48, 130.47, 129.4, 129.3, 128.6, 128.5, 125.2, 123.8, 123.2, 122.6, 113.7, 111.9, 100.8, 84.0, 70.9, 27.7, one carbon was phased out, or overlapped during acquisition, and was not observed; IR ATR-(neat): υ̅~max~ = 3061, 3032, 2977, 2932, 1729, 1615, 1584, 1485, 1366, 1325, 1157, 1025, 769, 694 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~40~H~33~N~5~O~3~ 631.2583; Found: 631.2561.

### 2-\[6-(5,6-Diphenyl-\[1,2,4\]triazin-3-yl)-pyridin-2-yl\]-indole-1,6-dicarboxylic Acid 1-*tert*-Butyl Ester 6-Methyl Ester (**9**) {#sec4.4.8}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-diphenyl-\[1,2,4\] triazine (**1**) (0.1000 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), (1-(*tert*-butylcarbonyl)-6-(methoxycarbonyl)-indol-2-yl)boronic acid (0.0868 g, 0.272 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.26, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.087 g, 58%; pale green/yellow solid; melting point = 184.6--186.2 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.95--8.94 (br-m, 1H), 8.70 (dd, *J* = 0.9, 8.0 Hz, 1H), 8.23 (t, *J* = 7.9 Hz, 1H), 7.97 (dd, *J* = 0.9, 7.9 Hz, 1H), 7.96 (dd, *J* = 1.5, 8.2 Hz, 1H), 7.79 (d, *J* = 8.2 Hz, 1H), 7.74--7.70 (m, 2H), 7.68--7.65 (m, 2H), 7.53--7.39 (m, 6H), 7.10 (s, 1H), 3.95 (s, 3H), 1.29 (s, 9H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 167.7, 161.7, 157.5, 156.8, 154.0, 153.8, 150.4, 143.3, 138.7, 138.0, 136.8, 133.4, 131.54, 131.5× (overlaps with 131.54), 130.9, 130.5, 129.4, 129.3, 127.5, 125.7, 124.7, 123.9, 121.9, 117.2, 111.4, 84.8, 52.4, 27.7; IR ATR-(neat): υ̅~max~ = 2999, 2952, 1727, 1714, 1611, 1585, 1489, 1439, 1409, 1393, 1375, 1334, 1298, 1219, 1093, 768, 705, 692 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~35~H~29~N~5~O~4~ 583.2220; Found: 583.2212.

### 2-\[6-(5,6-Diphenyl-\[1,2,4\]triazin-3-yl)-pyridin-2-yl\]-1*H*-indole (**10**) {#sec4.4.9}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-diphenyl-\[1,2,4\]triazine (**1**) (0.1006 g, 0.258 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.8 mg, 0.013 mmol, 0.05 equiv), 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1*H*-indole (0.0656 g, 0.270 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0842 g, 0.258 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.30, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.090 g, 82%; medium brown powder; melting point = 211.6--213.2 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 11.11 (br-s, 1H), 8.50 (dd, *J* = 0.9, 7.7 Hz, 1H), 8.22 (dd, *J* = 0.9, 8.0 Hz, 1H), 8.12 (t, *J* = 7.8 Hz, 1H), 7.79--7.76 (m, 2H), 7.72--7.69 (m, 2H), 7.66--7.61 (br-m, 2H), 7.56--7.43 (m, 6H), 7.30--7.28 (br-m, 1H), 7.19 (ddd, *J* = 1.1, 7.0, 8.5 Hz, 1H), 7.06 (ddd, *J* = 1.1, 7.0, 8.5 Hz, 1H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~S=O): δ = 160.6, 156.4, 155.8, 152.6, 151.0, 138.2, 137.4, 136.6, 135.44, 135.38, 130.7, 129.9, 129.7, 19.4, 128.6, 128.5, 129.3, 122.6, 121.6, 120.7, 119.6, 112.3, 101.8; IR (ATR-solid): υ̅~max~ = 3450, 1703, 1590, 1567, 1505, 1483, 1442, 1404, 1378, 775, 701 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~28~H~19~N~5~ 425.1640; Found: 425.1623.

### 3-(6-Benzofuran-2-yl-pyridin-2-yl)-5,6-diphenyl-\[1,2,4\] Triazine (**11**) {#sec4.4.10}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-diphenyl-\[1,2,4\] triazine (**1**) (0.1000 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (5.6 mg, 0.010 mmol, 0.004 equiv), XantPhos (11.2 mg, 0.013 mmol, 0.008 equiv), Benzo\[*b*\]furan-2-ylboronic acid (0.0450 g, 0.277 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.40, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.040 g, 37%; bright yellow solid; melting point = 183.9--184.7 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.60 (dd, *J* = 1.1, 7.6 Hz, 1H), 8.23 (t, *J* = 7.8 Hz, 1H), 8.22--8.18 (m, 1H), 7.80--7.76 (m, 3H), 7.75 (d, *J* = 0.9 Hz, 1H), 7.72--7.69 (m, 2H), 7.68--7.65 (m, 1H), 7.56--7.40 (m, 7H), 7.33 (dt, *J* = 1.0, 7.4 Hz, 1H); ^13^C NMR{^1^H} (125 MHz, CDCl~3~): δ = 160.7, 156.6, 156.3, 155.6, 155.0, 153.3, 150.1, 138.0, 135.8, 135.5, 131.0, 130.2, 130.0, 129.7, 129.0, 128.8, 128.7, 125.5, 123.4, 122.0, 122.4, 111.7, 106.1, one carbon was phased out, or overlapped during acquisition, and was not observed; IR ATR-(neat): υ̅~max~ = 3060, 2925, 2854, 1603, 1575, 1560, 1493, 1446, 1381, 1258, 1171, 810, 767 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~28~H~18~N~4~O 426.1481; Found: 426.1461.

### 2-\[6-(5,6-Di-*p*-tolyl-\[1,2,4\]triazin-3-yl)-pyridin-2-yl\]-4-methyl-indole-1-carboxylic Acid *tert*-Butyl Ester (**13**) {#sec4.4.11}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-di-*p*-tolyl-\[1,2,4\]triazine (0.1002 g, 0.240 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.9 mg, 0.007 mmol, 0.025 equiv), XantPhos (7.1 mg, 0.012 mmol, 0.05 equiv), 1-(*tert*-butylcarbonyl)-4-(methyl)-indol-2-yl)boronic acid (0.0697 g, 0.253 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.780 g, 0.239 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.20 mL, 0.20 M total), *R*~*f*~ = 0.33, 40% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.105 g, 77%; yellow solid; melting point = 122.6--124.1 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.63 (dd, *J* = 1.0, 7.9 Hz, 1H), 8.18 (t, *J* = 7.9 Hz, 1H), 8.03 (dd, *J* = 0.6, 8.3 Hz, 1H), 7.92 (dd, *J* = 1.0, 7.8 Hz, 1H), 7.65--7.62 (m, 2H), 7.58--7.55 (m, 2H), 7.30--7.26 (m, 3H), 7.25--7.21 (m, 2H), 7.11--7.08 (m, 1H), 7.06 (d, *J* = 0.8 Hz, 1H), 2.57 (s, 3H), 2.40 (s, 3H), 2.37 (s, 3H), 1.26 (s, 9H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 161.4, 157.1, 156.3, 154.6, 153.7, 150.8, 141.9, 140.5, 139.8, 138.5, 138.3, 134.1, 134.0, 131.3, 130.8, 130.3, 130.0, 129.9, 129.3, 125.9, 125.3, 124.0, 123.2, 112.9, 110.3, 83.9, 27.7, 21.4, 21.3, 18.5; IR (ATR-(CH~3~)~2~C=O): υ̅~max~ = 3394, cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~36~H~33~N~5~O~2~ 567.2634; Found: 567.2639.

### 2-\[6-(5,6-Di-*p*-tolyl-\[1,2,4\]triazin-3-yl)-pyridin-2-yl\]-indole-1-carboxylic Acid *tert*-Butyl Ester (**14**) {#sec4.4.12}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-di-*p*-tolyl-\[1,2,4\]triazine (0.1010 g, 0.242 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.9 mg, 0.007 mmol, 0.025 equiv), XantPhos (7.6 mg, 0.013 mmol, 0.05 equiv), 1-(*tert*-butylcarbonyl)-indol-2-yl)boronic acid (0.0670 g, 0.257 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0781 g, 0.240 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.21 mL, 0.20 M total), *R*~*f*~ = 0.52, 20% ethyl acetate:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then isocratic holds (2); isolated yield 0.051 g, 38%; taupe powder; melting point = 206.8--209.1 °C; ^1^H NMR (500 MHz, CD~5~CD~3~): δ = 8.65 (dd, *J* = 0.7, 7.8 Hz, 1H), 8.55 (d, *J* = 8.5 Hz, 1H), 7.63--7.59 (m, 2H), 7.56--7.51 (m, 2H), 7.46--7.42 (br-m, 1H), 7.39 (t, *J* = 7.8 Hz, 1H), 7.29--7.23 (m, 2H), 7.18--7.12 (m, 1H), 6.89--6.85 (m, 2H), 6.79--6.75 (m, 2H), 6.62 (s, 1H), 2.04 (s, 3H), 1.96 (s, 3H), 1.16 (s, 9H); ^13^C NMR{^1^H} (125 MHz, CD~5~CD~3~): δ = 161.1, 156.2, 155.4, 154.5, 153.5, 150.3, 140.9, 139.8, 139.6, 138.7, 136.6, 133.8, 133.6, 130.5, 129.9, 129.5, 129.4, 129.3, 124.4, 123.1, 122.5, 121.2, 115.7, 111.6, 82.8, 27.5, 21.12, 21.1× (overlaps with 21.12), one carbon was phased out, or overlapped during acquisition, and was not observed; IR (ATR-solid): υ̅~max~ = 3054, 3058, 2975, 2916, 1738, 1606, 1587, 1493, 1365, 1315, 1155, 1130, 846, 815, 800, 750 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~35~H~31~N~5~O~2~ 553.2478; Found: 553.2487.

### 2-{6-\[5,6-Bis-(4-fluoro-phenyl)-\[1,2,4\]triazin-3-yl\]-pyridin-2-yl}-5-fluoro-indole-1-carboxylic Acid *tert*-Butyl Ester (**15**) {#sec4.4.13}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-bis-(4-fluoro-phenyl)-\[1,2,4\] triazine (0.1091 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), (1-(*tert*-butylcarbonyl)-5-(fluoro)-indol-2-yl)boronic acid (0.0754 g, 0.270 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.75, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.093 g, 63%; bright yellow solid; melting point = 189.6--191.4 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.66 (dd, *J* = 0.9, 7.9 Hz, 1H), 8.24--8.21(m, 2H), 7.92 (dd, *J* = 0.8, 7.7 Hz, 1H), 7.82--7.76 (m, 2H), 7.75--7.71 (m, 2H), 7.42 (dd, *J* = 2.6, 8.9 Hz, 1H), 7.29--7.17 (m, 5H), 7.00 (s, 1H), 1.27 (s, 9H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 164.2 (d, *J* = 250.7 Hz), 163.6 (d, *J* = 249.1 Hz), 160.8, 159.3 (d, *J* = 238.0 Hz), 155.6, 155.0, 153.4, 152.7, 149.6, 141.1, 137.7, 134.1, 132.53, 132.49, 132.45, 132.1 (t, *J* = 3.0 Hz), 132.1× (overlaps with 132.1), 131.9 (d, *J* = 8.8 Hz), 129.74, 129.70 (d, *J* = 10.6 Hz), 124.8, 122.8, 115.7 (d, *J* = 9.2 Hz), 115.5 (d, *J* = 8.8 Hz), 112.65, 112.60 (d, *J* = 25.7 Hz), 112.5, 110.5 (d, *J* = 3.9 Hz), 106.2 (d, *J* = 23.4 Hz), 83.5, 26.8; IR ATR-(neat): υ̅~max~ = 3079, 2985, 1726, 1599, 1588, 1571, 1487, 1474, 1447, 1384, 1328, 1223, 1156, 1110, 843, 803 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~33~H~24~F~3~N~5~O~2~ 579.1882; Found: 579.1863.

### 2-{6-\[5,6-Bis-(4-fluoro-phenyl)-\[1,2,4\]triazin-3-yl\]-pyridin-2-yl}-5-(*tert*-butyl-dimethyl-silanyloxy)-indole-1-carboxylic Acid *tert*-Butyl Ester (**16**) {#sec4.4.14}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-bis-(4-fluoro-phenyl)-\[1,2,4\] triazine (0.1091 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), (1-(*tert*-butylcarbonyl)-6-(*tert*-butyldimethyl-silyl)-indol-2-yl)boronic acid (0.1057 g, 0.270 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.60, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.103 g, 58%; bright yellow solid; melting point = 157.8--158.9 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.64 (dd, *J* = 0.9, 7.9 Hz, 1H), 8.18 (t, *J* = 7.9 Hz, 1H), 8.10--8.08 (m, 1H), 7.88 (dd, *J* = 0.9, 7.8 Hz, 1H), 7.81--7.77 (m, 2H), 7.76--7.71 (m, 2H), 7.29--7.20 (m, 4H), 7.15 (br-d, *J* = 2.4 Hz, 1H), 6.97 (dd, *J* = 2.5, 9.0 Hz, 1H), 6.90 (br-s, 1H), 1.26 (s, 9H), 1.03 (s, 9H), 0.25 (9s, 6H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 165.1 (d, *J* = 249.6 Hz), 164.5 (d, *J* = 249.6 Hz), 161.8, 156.5, 155.8, 154.7, 153.5, 152.5, 150.7, 141.0, 138.4, 133.9, 133.4 (d, *J* = 9.5 Hz), 133.1, 133.1× (overlaps with 133.1), 132.8 (d, *J* = 8.3 Hz), 130.7, 125.6, 123.5, 119.3, 116.6 (d, *J* = 9.1 Hz), 116.4 (d, *J* = 9.1 Hz), 116.2, 111.8, 111.6, 83.9, 27.7, 26.1, 18.8, −4.3; IR ATR-(neat): υ̅~max~ = 3064, 2982, 2958, 2929, 2856, 1726, 1601, 1592, 1503, 1471, 1456, 1361, 1345, 1227, 1157, 1127, 841 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~39~H~39~F~2~N~5~O~3~Si 691.2790; Found: 691.2769.

### 2-{6-\[5,6-Bis-(3-methoxy-phenyl)-\[1,2,4\]triazin-3-yl\]-pyridin-2-yl}-5-methoxy-indole-1-carboxylic Acid *tert*-Butyl Ester (**17**) {#sec4.4.15}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-bis-(3-methoxy-phenyl)-\[1,2,4\]triazine (0.1150 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), (1-(*tert*-buty10-foldlcarbonyl)-5-(methoxy)-indol-2-yl)boronic acid (0.0786 g, 0.270 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total, *R*~*f*~ = 0.22, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.097 g, 61%; bright yellow solid; melting point = 111.6--112.8 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.65 (dd, *J* = 0.9, 7.9 Hz, 1H), 8.18 (t, *J* = 8.0 Hz, 1H), 8.10 (br-d, *J* = 9.0 Hz, 1H), 7.89 (dd, *J* = 0.9, 7.9 Hz, 1H), 7.36 (t, *J* = 7.9 Hz, 1H), 7.34--7.30 (m, 2H), 7.29--7.26 (m, 2H), 7.21--7.18 (m, 2H), 7.07--7.04 (m, 2H), 7.01 (dd, *J* = 2.6, 9.1 Hz, 1H), 6.93 (br-s, 1H), 3.86 (s, 3H), 3.77 (s, 3H), 3.73 (s, 3H), 1.27 (s, 9H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 161.8, 160.7, 160.5, 157.3, 157.2, 156.6, 154.6, 153.5, 150.8, 140.9, 138.4, 138.11, 138.08, 133.4, 130.53, 130.47, 130.4, 125.5, 123.4, 123.0, 122.7, 117.5, 116.24, 116.2× (overlaps with 116.24), 115.9, 115.7, 114.9, 111.8, 104.1, 83.9, 55.8, 55.64, 55.61, 27.7; IR (ATR-(neat)): υ̅~max~ = 3076, 2976, 2934, 2834, 1728, 1582, 1449, 1366, 1355, 1322, 1219, 1158. 1125, 1029, 848, 788, 701 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~36~H~33~N~5~O~5~ 615.2482; Found: 615.2458.

### 2-{6-\[5,6-Bis-(4-cyclopropyl-phenyl)-\[1,2,4\]triazin-3-yl\]-pyridin-2-yl}-4-methyl-indole-1-carboxylic Acid *tert*-Butyl Ester (**18**) {#sec4.4.16}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-bis-(4-cyclopropyl-phenyl)-\[1,2,4\]triazine (0.1264 g, 0.270 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), 1-(*tert*-butylcarbonyl)-4-(methyl)-indol-2-yl)boronic acid (0.0743 g, 0.270 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.63, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.108 g, 64%; light yellow powder; melting point = 153.1--154.3 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.62 (dd, *J* = 1.0, 7.9 Hz, 1H), 8.17 (t, *J* = 7.9 Hz, 1H), 8.03 (br-d, *J* = 8.6 Hz, 1H), 7.91 (dd, *J* = 0.9, 7.8 Hz, 1H), 7.65--7.61 (m, 2H), 7.58--7.54 (m, 2H), 7.29 (dd, *J* = 7.5, 8.6 Hz, 1H), 7.19--7.15 (m, 2H), 7.14--7.10 (m, 2H), 7.09--7.08 (m, 1H), 7.06 (d, *J* = 0.7 Hz, 1H), 2.57 (s, 3H), 2.03--1.95 (m, 2H), 1.26 (s, 9H), 1.06--1.00 (m, 4H), 0.79--0.74 (m, 4H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 160.5, 156.1, 155.3, 153.7, 152.9, 149.9, 147.8, 146.3, 138.9, 137.6, 137.4, 133.0, 132.9, 130.5, 129.9, 129.4, 128.4, 125.5, 125.3, 125.0, 124.4, 123.2, 122.4, 112.1, 109.3, 83.1, 26.8, 17.6, 15.1, 15.0, 9.7, 9.5; IR (ATR-(neat)): υ̅~max~ = 3081, 3003, 2978, 2931, 1732, 1609, 1589, 1569, 1456, 1418, 778 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~40~H~37~N~5~O~2~ 619.2947; Found: 619.2968.

### 2-{6-\[5,6-Bis-(4-cyclopropyl-phenyl)-\[1,2,4\]triazin-3-yl\]-pyridin-2-yl}-1*H*-indole (**19**) {#sec4.4.17}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-bis-(4-cyclopropyl-phenyl)-\[1,2,4\]triazine (0.1264 g, 0.270 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1*H*-indole (0.0691 g, 0.284 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.52, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes; isolated yield 0.083 g, 61%; bright yellow powder; melting point = 242.5--243.7 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 11.10 (br-s, 1H), 8.47 (dd, *J* = 1.0, 7.8 Hz, 1H), 8.20 (dd, *J* = 1.0, 8.0 Hz, 1H), 8.10 (t, *J* = 7.8 Hz, 1H), 7.70--7.67 (m, 2H), 7.66--7.62 (m, 2H), 7.61--7.58 (m, 2H), 7.29--7.23 (br-m, 1H), 7.21--7.14 (m, 5H), 7.08--7.04 (m, 1H), 2.04--1.97 (m, 2H), 1.08--1.02 (m, 4H), 0.81--0.76 (m, 4H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~S=O): δ = 160.2, 156.0, 155.2, 152.7, 151.0, 145.9, 138.2, 137.4, 136.7, 132.4, 132.3, 129.8, 129.2, 128.3, 125.5, 125.3, 122.6, 122.3, 121.6, 120.8, 119.6, 112.3, 101.7, 15.2, 15.1, 10.3, 10.1; IR (ATR-(neat)): υ̅~max~ = 3318, 3080, 3056, 1609, 1590, 1488, 1396, 1356, 1338, 1148, 899, 817, 787 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~34~H~27~N~5~ 505.2266; Found: 505.2281.

### 2-{6-\[5,6-Bis-(3-methoxy-phenyl)-\[1,2,4\]triazin-3-yl\]-pyridin-2-yl}-4-methyl-indole-1-carboxylic Acid *tert*-Butyl Ester (**20**) {#sec4.4.18}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-bis-(3-methoxy-phenyl)-\[1,2,4\]triazine (0.1150 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), 1-(*tert*-butylcarbonyl)-4-(methyl)-indol-2-yl)boronic acid (0.0742 g, 0.270 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.36, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes; isolated yield 0.087 g, 56%; gold solid; melting point = 155.7--157.2 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.65 (dd, *J* = 0.9, 7.8 Hz, 1H), 8.19 (t, *J* = 7.8 Hz, 1H), 8.03 (br-d, *J* = 8.4 Hz, 1H), 7.93 (dd, *J* = 0.9, 7.8 Hz, 1H), 7.36 (t, *J* = 8.0 Hz, 1H), 7.34--7.29 (m, 2H), 7.28--7.25 (m, 3H), 7.21--7.17 (m, 1H), 7.10--7.08 (m, 1H), 7.07--7.06 (m, 1H), 7.05--7.03 (m, 2H), 3.77 (s, 3H), 3.73 (s, 3H), 2.57 (s, 3H), 1.27 (s, 9H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 161.7, 160.7, 160.5, 157.3, 156.6, 154.7, 153.5, 150.8, 139.8, 138.6, 138.4, 138.11, 138.06, 131.4, 130.5, 130.3, 129.3, 126.0, 125.4, 124.0, 123.3, 123.0, 122.7, 117.5, 116.2, 115.8, 115.7, 112.9, 110.3, 83.9, 55.64, 55.61, 27.7, 18.5; IR (ATR-(neat)): υ̅~max~ = 2977, 2918, 2839, 1728, 1588, 1496, 1457, 1423, 1349, 1325, 1146, 789, 774, 699, 689 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~36~H~33~N~5~O~4~ 599.2533; Found: 599.2530.

### 2-{6-\[5,6-Bis-(4-butyl-phenyl)-\[1,2,4\]triazin-3-yl\]-pyridin-2-yl}-5-fluoro-indole-1-carboxylic Acid *tert*-Butyl Ester (**21**) {#sec4.4.19}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-bis-(3-methoxy-phenyl)-\[1,2,4\]triazine (0.1286 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), total (1-(*tert*-butylcarbonyl)-5-(fluoro)-indol-2-yl)boronic acid (0.0754 g, 0.270 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.258 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.68, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes; isolated yield 0.127 g, 75%; bright yellow solid; melting point = 81.3--82.4 °C; ^1^H NMR (500 MHz, CD~3~CN): δ = 8.60 (d, *J* = 8.0 Hz, 1H), 8.16 (dd, *J* = 4.5, 8.9 Hz, 1H), 8.10 (t, *J* = 8.0 Hz, 1H), 7.81 (d, *J* = 7.8 Hz, 1H), 7.54--7.48 (m, 4H), 7.38 (dd, *J* = 2.6, 9.1 Hz, 1H), 7.27--7.24 (m, 2H), 7.23--7.20 (m, 2H), 7.17 (dt, *J* = 2.6, 9.3 Hz, 1H), 6.92 (s, 1H), 2.70--2.61 (m, 4H), 1.65--1.54 (m, 4H), 1.40--1.29 (m, 4H), 0.94 (t, *J* = 7.3 Hz, 3H), 0.91 (t, *J* = 7.4 Hz, 3H); ^13^C NMR{^1^H} (125 MHz, CD~3~CN): δ = 161.5, 161.2, 159.3, 157.7, 157.2, 154.1, 153.7, 147.1, 145.9, 141.9, 138.7, 135.0, 134.4, 134.3, 130.7, 130.6 (d, *J* = 130.6 Hz), 130.4, 129.5, 129.4, 125.9, 123.8, 116.9 (d, *J* = 9.3 Hz), 113.6 (d, *J* = 25.4 Hz), 111.5 (d, *J* = 4.42 Hz), 107.3 (d, *J* = 24.0 Hz), 84.9, 35.95, 35.93, 34.2, 34.1, 27.7, 22.99, 22.96, 14.19, 14.16; IR (ATR-(neat)): υ̅~max~ = 2956, 2929, 2858, 1732, 1609, 1588, 1571, 1491, 1474, 1446, 1368, 1347, 1328, 1156, 1111, 848, 800 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~41~H~42~FN~5~O~2~ 655.3323; Found: 655.3328.

### 2-{6-\[5,6-Bis-(4-butyl-phenyl)-\[1,2,4\]triazin-3-yl\]-pyridin-2-yl}-5-methoxy-indole-1-carboxylic Acid *tert*-Butyl Ester (**22**) {#sec4.4.20}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-bis-(3-methoxy-phenyl)-\[1,2,4\]triazine (0.01286 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), (1-(*tert*-butylcarbonyl)-5-(methoxy)-indol-2-yl)boronic acid (0.0786 g, 0.270 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.54, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 8% isocratic hold; isolated yield 0.126 g, 73%; bright yellow solid; melting point = 152.6--153.4 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.62 (d, *J* = 7.9 Hz, 1H), 8.17 (t, *J* = 7.9 Hz, 1H), 8.11 (d, *J* = 9.0 Hz, 1H), 7.87 (d, *J* = 7.7 Hz, 1H), 7.66--7.63 (m, 2H), 7.60--7.57 (m, 2H), 7.31--7.27 (m, 2H), 7.26--7.23 (m, 2H), 7.19 (d, *J* = 2.5 Hz, 1H), 7.01 (dd, *J* = 2.6 Hz, 2.39 (s, 3H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 161.5, 157.23, 157.21, 156.5, 154.6, 153.8, 150.7, 146.8, 145.5, 140.9, 138.3, 134.35, 134.31, 133.3, 130.8, 130.5, 130.3, 129.4, 129.3, 125.4, 123.3, 116.8, 114.9, 111.7, 104.1, 83.9, 55.8, 36.01, 35.98, 34.2, 34.1, 27.7, 23.0, 14.18, 14.16; IR (ATR-(neat)): υ̅~max~ = 2953, 2928, 2869, 2859, 1727, 1609, 1588, 1569, 1490, 1477, 1455, 1386, 1367, 1355, 1326, 1218, 1162, 1130, 1019, 849, 805 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~42~H~45~N~5~O~3~ 667.3522; Found: 667.3527.

### 6-Benzyloxy-2-(6-{5,6-bis-\[4-(3-methyl-butyl)-phenyl\]-\[1,2,4\]triazin-3-yl}-pyridin-2-yl)-indole-1-carboxylic Acid *tert*-Butyl Ester (**23**) {#sec4.4.21}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-bis-\[4-(3-methyl-butyl)-phenyl\]-\[1,2,4\]triazine (0.1359 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), (1-(*tert*-butylcarbonyl)-6-(benzyloxy)-indol-2-yl)boronic acid (0.0992 g, 0.264 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), *R*~*f*~ = 0.48, 20% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes; isolated yield 0.083 g, 42%; gold solid; melting point = 100.3--101.5 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.61 (dd, *J* = 0.8, 7.9 Hz, 1H), 8.15 (t, *J* = 7.8 Hz, 1H), 7.90 (d, *J* = 2.2 Hz, 1H), 7.87 (dd, *J* = 0.9, 7.9 Hz, 1H), 7.67--7.63 (m, 2H), 7.60--7.54 (m, 5H), 7.44--7.39 (m, 2H), 7.36--7.32 (m, 1H), 7.31--7.28 (m, 2H), 7.27--7.24 (m, 2H), 7.03 (dd, *J* = 2.3, 8.5 Hz, 1H), 6.94 (br-s, 1H), 5.23 (br-s, 2H), 2.73--2.63 (m, 4H), 1.65--1.48 (m, 6H), 1.26 (s, 9H), 0.95 (d, *J* = 6.5 Hz, 6H), 0.94 (d, *J* = 6.5 Hz, 6H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 161.6, 158.5, 157.2, 156.4, 154.6, 153.7, 150.9, 147.1, 145.7, 139.8, 139.4, 138.4, 138.3, 134.31, 134.27, 130.8, 130.3, 129.4, 129.3, 129.25, 128.6, 128.5, 125.0, 123.8, 123.1, 122.6, 113.7, 111.8, 100.8, 84.0, 70.9, 41.4, 41.3, 34.20, 34.17, 28.4, 27.7, 27.7× (overlaps with 27.7, 22.79, 22.76; IR (ATR-(neat)): υ̅~max~ = 3032, 2953, 2930, 2867, 1730, 1610, 1584, 1570, 1486, 1366, 1325, 1158, 820 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~50~H~53~N~5~O~3~ 771.4148; Found: 771.4153.

### 2-(6-{5,6-Bis-\[4-(3-methyl-butyl)-phenyl\]-\[1,2,4\]triazin-3-yl}-pyridin-2-yl)-1*H*-indole (**24**) {#sec4.4.22}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-bis-\[4-(3-methyl-butyl)-phenyl\]-\[1,2,4\]triazine (0.2472 g, 0.468 mmol, 1.00 equiv), palladium dibenzylidene acetone (6.7 mg, 0.012 mmol, 0.025 equiv), XantPhos (13.6 mg, 0.024 mmol, 0.05 equiv), 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1*H*-indole (0.1195 g, 0.492 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.1525 g, 0.468 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (2.34 mL, 0.20 M total), *R*~*f*~ = 0.30, 5% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes, gradient then 4% isocratic hold; isolated yield 0.163 g, 61%; pale-yellow solid; melting point = 195.1--196.4 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 11.11 (br-s, 1H), 8.48 (dd, *J* = 0.9, 7.7 Hz, 1H), 8.20 (dd, *J* = 0.9, 8.0 Hz, 1H), 8.10 (t, *J* = 7.9 Hz, 1H), 7.72--7.68 (m, 2H), 7.66--7.60 (m, 4H), 7.34--7.31 (m, 2H), 7.30--7.27 (m, 3H), 7.19 (ddd, *J* = 1.1, 7.6, 8.7 Hz, 1H), 7.06 (ddd, *J* = 1.1, 7.4, 8.5 Hz, 1H), 2.75--2.67 (m, 4H), 1.67--1.50 (m, 6H), 0.97 (d, *J* = 6.5 Hz, 6H), 0.95 (d, *J* = 6.6 Hz, 6H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 161.4, 157.3, 156.4, 154.0, 152.2, 147.1, 145.7, 138.7, 138.4, 137.8, 134.4, 134.3, 131.0, 130.4, 130.1, 129.4, 129.3, 123.7, 123.1, 122.3, 121.8, 120.7, 113.0, 102.1, 41.4, 41.3, 34.25, 34.21, 28.4, 28.4× (overlaps with 28.4), 22.82, 22.78; IR (ATR-(neat)): υ̅~max~ = 3435, 3053, 2954, 2928, 2967, 1609, 1591, 1568, 1496, 1467, 1382, 1365, 820, 783 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~38~H~39~N~5~ 565.3205; Found: 565.3190.

### 6-Benzyloxy-2-(6-{5,6-bis-\[4-(3,3-dimethyl-butyl)-phenyl\]-\[1,2,4\]triazin-3-yl}-pyridin-2-yl)-1*H*-indole (**25**) {#sec4.4.23}

Prepared according to the general procedure discussed above with 3-(6 bromo-pyridin-2-yl)-5,6-bis-\[4-(3,3-dimethyl-butyl)-phenyl\]-\[1,2,4\]triazine (0.1430 g, 0.218 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), (1-(*tert*-butylcarbonyl)-6-(benzyloxy)-indol-2-yl)boronic acid (0.0992 g, 0.264 mmol, 1.05 equiv), and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total), Two purifications were required to obtain material pure enough for characterization, *R*~*f*~ = 0.26 5% \[(3:1) ethyl acetate:acetone\]:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes; isolated yield 0.025 g, 12%; bright yellow solid; melting point = 158.9--160.1 °C; ^1^H NMR (500 MHz, (CD~3~)~2~C=O): δ = 8.61 (dd, *J* = 0.9, 7.9 Hz, 1H), 8.15 (t, *J* = 7.8 Hz, 1H), 7.90 (br-d, *J* = 2.3 Hz, 1H), 7.87 (dd, *J* = 0.9, 7.8 Hz), 7.68--7.64 (m, 2H), 7.61--7.54 (m, 5H), 7.44--7.39 (m, 2H), 7.36--7.32 (m, 1H), 7.31--7.29 (m, 2H), 7.28--7.25 (m, 2H), 7.03 (dd, *J* = 2.4, 8.7 Hz, 1H), 6.94 (d, *J* = 0.5 Hz, 1H), 5.23 (s, 2H), 2.72--2.62 (m, 4H), 1.59--1.50 (m, 4H), 1.27 (s, 9H), 0.99 (s, 9H), 0.98 (s, 9H); ^13^C NMR{^1^H} (125 MHz, (CD~3~)~2~C=O): δ = 161.5, 158.5, 157.2, 156.4, 154.6, 153.4, 150.9, 147.6, 146.3, 139.8, 139.4, 138.4, 138.3, 134.3, 134.2, 130.9, 130.4, 129.4, 129.27, 129.25, 128.6, 128.5, 125.0, 123.8, 123.0, 122.6, 113.7, 111.8, 100.8, 84.0, 70.9, 46.8, 46.7, 31.8, 31.7, 31.1, 31.1× (overlaps with 31.1), 29.62, 29.59, 27.7; IR (ATR-(neat)): υ̅~max~ = 3062, 3032, 2952, 2907, 2865, 1732, 1611, 1585, 1486, 1365, 1327, 844, 820 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~52~H~57~N~5~O~3~ 799.4461; Found: 799.4437.

### 5,6-Diphenyl-3-(6-phenyl-pyridin-2-yl)-\[1,2,4\]triazine (**26**) {#sec4.4.24}

Prepared according to the general procedure discussed above with 3-(6-bromo-pyridin-2-yl)-5,6-diphenyl-\[1,2,4\] triazine (**1**) (0.1000 g, 0.257 mmol, 1.00 equiv), palladium dibenzylidene acetone (3.7 mg, 0.006 mmol, 0.025 equiv), XantPhos (7.4 mg, 0.013 mmol, 0.05 equiv), the requisite boron reagent (PhB(OH)~2~, PhBF~3~K, PhBpin, or PhB-MIDA) 1.05 equiv, and Cs~2~CO~3~ (0.0838 g, 0.257 mmol, 1.00 equiv). The resulting mixture was slurried in a 4:1 mixture of CPME:H~2~O (1.29 mL, 0.20 M total, *R*~*f*~ = 0.51 20% ethyl acetate:hexanes; eluent, \[(3:1) ethyl acetate:acetone\]:hexanes; isolated yield 0.069 g, 69%; bright yellow solid; melting point = 164.5--167.2 °C; ^1^H NMR (500 MHz, CDCl~3~): δ = 8.61 (d, *J* = 7.6 Hz, 1H), 8.24--8.21 (m, 2H), 8.00 (t, *J* = 7.7 Hz, 1H), 7.96--7.94 (m, 1H), 7.76--7.73 (m, 2H), 7.69--7.66 (m, 2H), 7.55--7.50 (m, 2H), 7.49--7.37 (m, 7H); ^13^C NMR{^1^H} (125 MHz, CDCl~3~): δ = 161.0, 158.0, 156.4, 156.1, 152.9, 139.0, 137.9, 135.8, 135.5, 130.9, 130.1, 129.9, 129.7, 129.4, 128.9, 128.8, 128.7, 127.3, 122.6, 122.1; IR (ATR-(neat)): υ̅~max~ = 3054, 2924, 2853, 1577, 1566, 1502, 1490, 1482, 1443, 1381, 760, 702, 690 cm^--1^; HRMS (EI): *m*/*z*: \[M\]^+^ Calcd for C~26~H~18~N~4~ 386.1531; Found: 386.1531.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.9b02891](http://pubs.acs.org/doi/abs/10.1021/acsomega.9b02891).Copies of ^1^H and ^13^C NMR spectra as well as purification chromatograms for all compounds ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b02891/suppl_file/ao9b02891_si_001.pdf))
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